Corcept Therapeutics Incorporated · NASDAQ:CORT
Maduck Sean sold 25,000 Corcept Therapeutics Incorporated shares (Form 4)
Traded Sep 1 to Sep 2, 2026 · Filed Sep 3, 2026
From Sep 1 to Sep 2, 2026, Maduck Sean (See Remarks) sold 25,000 Corcept Therapeutics Incorporated shares at an average US$114.43 for US$2.86M under a trading plan, leaving 9,938 shares. Filed Sep 3, 2026 (Form 4).
- Sold
- 25,000 shares
- Price
- US$114.43 average (US$113.94 to US$115.61)
- Value
- US$2.86M
- Holding after
- 9,938 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Option exercise | 25,000 | US$8.27 | 34,755 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 11,730 | US$113.94 | 23,025 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 10,989 | US$114.71 | 12,036 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 2,281 | US$115.61 | 9,755 | Direct |
| Sep 1, 2026 | Common Stock | Award | 150 | US$113.38 | 9,905 | Direct |
| Sep 1, 2026 | Common Stock | Award | 150 | 10,055 | Direct | |
| Sep 2, 2026 | Common Stock | Shares withheld for tax | 117 | US$113.38 | 9,938 | Direct |
Source
Related
- Corcept Therapeutics Incorporated
- Maduck Sean
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Maduck Sean · Aug 27, 2026
- Form 4 · Maduck Sean · Aug 18, 2026
- Form 4 · Maduck Sean · Aug 12, 2026
- Form 4 · Maduck Sean · Aug 5, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026
- Form 4 · Robb Gary Charles · Sep 18, 2026